Operating Income (Loss) in USD of STANDARD BIOTOOLS INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Standard Biotools Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Standard Biotools Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$32.9M, a 23.4% decline year-over-year.
  • Standard Biotools Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$150M, a 8.06% decline year-over-year.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2024 was -$175M, a 129% decline from 2023.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2023 was -$76.6M, a 34.1% increase from 2022.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2022 was -$116M, a 72.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

STANDARD BIOTOOLS INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$150M -$32.9M -$6.24M -23.4% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$143M -$25.7M +$4.56M +15.1% 01 Apr 2025 30 Jun 2025 10-Q 15 Aug 2025
Q1 2025 -$148M -$33M +$27.2M +45.2% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 -$175M -$58.1M -$36.7M -172% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$139M -$26.7M -$5.53M -26.1% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$133M -$30.3M -$12.8M -73.4% 01 Apr 2024 30 Jun 2024 10-Q 15 Aug 2025
Q1 2024 -$120M -$60.2M -$43.6M -263% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 -$76.6M -$21.4M -$274K -1.3% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$76.3M -$21.2M +$7.86M +27.1% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$84.2M -$17.4M +$21.1M +54.8% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$105M -$16.6M +$10.9M +39.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$116M -$21.1M -$9.85M -87.5% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2025
Q3 2022 -$106M -$29M -$9.42M -48% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$96.9M -$38.6M -$21.3M -123% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$75.6M -$27.5M -$8.18M -42.4% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$67.5M -$11.3M +$5.65M +33.4% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 -$73.1M -$19.6M -$14.1M -259% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$59M -$17.3M -$3.54M -25.8% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$55.4M -$19.3M -$4.38M -29.3% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$51M -$16.9M -$7.72M -84.1% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 -$43.3M -$5.46M +$8.35M +60.5% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$51.7M -$13.7M +$910K +6.22% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$52.6M -$14.9M -$736K -5.18% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$51.8M -$9.18M +$1.94M +17.4% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2022
Q3 2019 -$53.8M -$13.8M -$2.19M -18.8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$51.6M -$14.6M -$1.85M -14.5% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 -$49.7M -$14.2M -$1.57M -12.5% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$48.2M -$11.1M -$2.38M -27.3% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 -$45.8M -$11.6M +$3.97M +25.5% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$49.8M -$12.8M +$3.7M +22.5% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$53.5M -$12.6M +$4.9M +28% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q4 2017 -$58.4M -$8.74M +$8.96M +50.6% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020
Q3 2017 -$67.3M -$15.6M +$2.88M +15.6% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 -$70.2M -$16.5M +$1.66M +9.12% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 -$71.9M -$17.5M +$1.33M +7.06% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 -$73.2M -$17.7M -$4M -29.2% 01 Oct 2016 31 Dec 2016 10-K 18 Mar 2019
Q3 2016 -$69.2M -$18.5M -$10.7M -137% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$58.5M -$18.1M -$3.48M -23.8% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 -$55M -$18.9M -$4.87M -34.8% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$50.2M -$13.7M -$3.86M -39.2% 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2018
Q3 2015 -$46.3M -$7.8M +$5.24M +40.2% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$51.5M -$14.7M -$2.28M -18.4% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$49.3M -$14M +$2.58M +15.6% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$51.8M -$9.83M -$5.19M -112% 01 Oct 2014 31 Dec 2014 10-K 03 Mar 2017
Q3 2014 -$46.6M -$13M -$8.1M -163% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 -$38.6M -$12.4M -$8.39M -210% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 -$30.2M -$16.6M -$11.5M -227% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$18.7M -$4.64M -$1.15M -33% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016
Q3 2013 -$17.5M -$4.95M -$1.04M -26.7% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 -$16.5M -$3.99M +$396K +9.03% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014
Q1 2013 -$16.9M -$5.07M +$1.22M +19.4% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 -$18.1M -$3.49M -$514K -17.3% 01 Oct 2012 31 Dec 2012 10-K 26 Feb 2015
Q3 2012 -$17.6M -$3.91M +$146K +3.6% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013
Q2 2012 -$17.7M -$4.39M +$2.27M +34.1% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013
Q1 2012 -$20M -$6.28M -$1.41M -28.8% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q4 2011 -$18.6M -$2.98M 01 Oct 2011 31 Dec 2011 10-K 12 Mar 2014
Q3 2011 -$4.06M -$956K -30.8% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$6.65M -$2.43M -57.5% 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 -$4.88M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$3.1M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$4.23M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

STANDARD BIOTOOLS INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$175M -$98.6M -129% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$76.6M +$39.6M +34.1% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$116M -$48.7M -72.3% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 -$67.5M -$16.4M -32.2% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 -$51M +$803K +1.55% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 -$51.8M -$3.68M -7.63% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022
2018 -$48.2M +$10.2M +17.5% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 -$58.4M +$14.8M +20.3% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 -$73.2M -$23M -45.9% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
2015 -$50.2M +$1.68M +3.24% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 -$51.8M -$33.2M -178% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017
2013 -$18.7M -$582K -3.22% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$18.1M +$495K +2.67% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015
2011 -$18.6M -$3.99M -27.4% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014
2010 -$14.6M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.